PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-World stock markets kick off 2021 at record highs

Mon, 04th Jan 2021 09:09

* MSCI All-Country World Index hits record high

* Bitcoin trades above $32,000

* Yuan surges nearly 1% vs. dollar

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Ritvik Carvalho

LONDON, Jan 4 (Reuters) - World stock markets hit record
highs on Monday, the first trading day of the new year, as
investors hoped the rollout of vaccines would ultimately lift a
global economy decimated by the COVID-19 pandemic.

The Chinese yuan surged nearly 1% against the dollar,
while the greenback plumbed its lowest levels against a basket
of peer currencies since April 2018. Bitcoin hovered
above $32,000 on the back of a blistering 800% rally since
mid-March.

European stocks opened higher, with Britain's FTSE 100
gaining 1.75%, Germany's DAX up 1.1%, Spain's
IBEX up 1.3% and Italy's FTSE MIB rising
0.7%.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, hit a record high and was up nearly
half a percent on the day after the start of trading in London.

"The year kicks off as 2020 ended, an everything rally with
the double V dichotomy (virus vs. vaccine) seeing the hopes that
either things get worse and stimulus ramps up or things get
better and, well, things get better so long as there’s no hint
of liquidity withdrawal and a taper tantrum," a trader said.

Asian stock markets also gained, although Japan's Nikkei 225
index shed early gains, falling 0.4% after Prime
Minister Yoshihide Suga confirmed the government was considering
a state of emergency for Tokyo and three surrounding prefectures
as the coronavirus spreads.

Despite the optimism over vaccines, investors are still
sounding caution over the path of the virus, which continues to
spread amidst the discovery of a new strain.

"The virus retains the upper hand for a while longer," said
Karl Steiner, chief quantiative strategist at SEB, noting that
vaccinations have had an uneven start, characterized by vaccine
shortages, vaccine resistance and delays.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

"We continue to believe that equities have further room to
rise in 2021 as monetary and fiscal stimulus measures provide a
tailwind, and we anticipate significant earnings growth as the
global economy recovers," said Mark Haefele, chief investment
officer at UBS Global Wealth Management.

Minutes of the Federal Reserve's December meeting are due on
Wednesday and should offer more detail on discussions about
making their forward policy guidance more explicit and the
chance of a further increase in asset buying this year.

E-Mini futures for the S&P 500 were steady after also
touching a record high.

PAYROLLS A RISK

The data calendar includes a raft of manufacturing surveys
across the globe, which will show how industry is coping with
the spread of the coronavirus, and the closely watched ISM
surveys of U.S. factories and services.

Chinese factory activity continued to accelerate in
December, though the PMI missed forecasts at 53.0.

Japanese manufacturing stabilised for the first time in two
years in December, while Taiwan picked up.

Friday sees the U.S. December payroll report where median
forecasts are for only a modest increase of 100,000 jobs.

Analysts as Barclays are tipping a fall of 50,000 in jobs,
which would be a shock to market hopes of a speedy recovery.

"A number of incoming indicators on activity point to slower
momentum as the economy closes out the year, including data on
labour markets where initial claims rose during the December
survey period," said economist Michael Gapen in a note.

Such a drop would add pressure on the Fed to ease further,
another burden for the dollar which is already buckling under
the weight of the massive U.S. budget and trade deficits.

In currencies, the euro pushed back up to $1.2281,
having run into profit-taking late last week when it reached the
highest since early 2018 at $1.2309. It gained almost 9% over
2020.

The dollar slipped to 102.80 yen. Sterling firmed to
$1.3690, levels last seen in mid-2018.

The decline in the dollar has been a support for gold,
leaving the metal 1.3% firmer at $1,931 an ounce.

Oil prices extended their rise after a couple of months of
solid gains, with Brent crossing $53 a barrel. U.S. crude
added 2% to $49.52 a barrel.

(Reporting by Ritvik Carvalho; additional reporting by Carolyn
Cohn in London and Wayne Cole in Sydney; Editing by Toby Chopra)

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.